Most Likely Diagnosis: Manic Episode with Psychotic Features
This patient is experiencing a manic episode with psychotic features (auditory hallucinations), and should be started immediately on either lithium, valproate, or an atypical antipsychotic (olanzapine, risperidone, quetiapine, or aripiprazole) as monotherapy.
Diagnostic Reasoning
Your patient presents with the cardinal features of mania:
- Decreased need for sleep (not just insomnia, but feeling no fatigue despite reduced sleep)
- Increased energy and goal-directed activity (hyperfocusing on studying, excessive cleaning)
- Impulsivity (excessive spending on takeout, deviation from baseline behavior)
- Psychotic symptoms (auditory hallucinations)
The presence of auditory hallucinations is particularly significant. Acute psychosis in a patient may be the first presentation of mania and needs careful assessment for associated features including marked decrease in need for sleep, affective lability, and lack of negative symptoms 1. Your patient demonstrates exactly this constellation.
Critical Diagnostic Considerations
The key distinction here is decreased need for sleep WITHOUT fatigue versus simple insomnia. This is a pathognomonic feature of mania that distinguishes it from primary insomnia disorder, where patients feel fatigued despite sleep difficulties 2. The pattern represents a marked departure from baseline functioning (she typically cooks at home but is now ordering out), which is essential for diagnosing mania 1.
Initial Treatment Approach
First-Line Monotherapy Options:
Start with ONE of the following 3, 4:
- Lithium (NNT = 3-13 for 3 weeks) 5
- Valproate/Divalproex
- Atypical antipsychotics:
- Olanzapine
- Risperidone
- Quetiapine
- Aripiprazole
- Ziprasidone
Choosing Between Options:
For mania with psychotic features, consider starting with an atypical antipsychotic as they address both manic symptoms and psychosis simultaneously 4. The most recent network meta-analysis (2025) showed tamoxifen had the highest efficacy, but atypical antipsychotics (olanzapine, paliperidone, quetiapine, ziprasidone, risperidone) demonstrated significantly better tolerability than placebo 4.
If symptoms are severe or response to monotherapy is inadequate within 1-2 weeks, escalate to combination therapy with a mood stabilizer (lithium or valproate) PLUS an atypical antipsychotic 3, 4. Combination therapies showed superior efficacy compared to their corresponding monotherapies 4.
Critical Actions
Stop any antidepressants immediately if she is taking them, as all guidelines unanimously recommend discontinuing antidepressants during manic phases 6, 3.
Important Caveats
- Assess for suicidality urgently - patients with bipolar disorder have high rates of suicide attempts 1
- Screen for substance abuse - this must be ruled out as a contributor 1
- Obtain family psychiatric history - particularly for mood disorders, as this supports the diagnosis 1
- Evaluate across multiple settings - the illness should be evident and impairing in different realms of life, not isolated to one setting 1
Duration Considerations
Ensure symptoms meet DSM-IV-TR duration criteria (at least 4 days for hypomania, 7 days for mania, or any duration if hospitalization is required) 1. If symptoms last hours to less than 4 days, consider Bipolar Disorder NOS 1.
Monitoring
Once acute treatment is initiated, plan for long-term maintenance treatment as the prognosis relies heavily on relapse prevention. Lithium has the strongest evidence for maintenance (NNT = 14 for 12 months, NNT = 3 for 24 months) 5.